Here, we investigated tumor-specific BCL2 expression with the automated quantitative analysis (AQUA) scoring system using the multiplex immunofluorescent (IF) imaging to assess the prognostic impact of quantitative BCL2 expression in patients with newly diagnosed DLBCL treated with R-CHOP. Here, BCL2 is linked to diffuse large B-cell lymphoma.